DROSERA ROTUNDIFOLIA (HOMEOLAB USA INC.)


Welcome to the PulseAid listing for the DROSERA ROTUNDIFOLIA drug offered from HOMEOLAB USA INC.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: HOMEOLAB USA INC.
NON-PROPRIETARY NAME: DROSERA ROTUNDIFOLIA
SUBSTANCE NAME: DROSERA ROTUNDIFOLIA
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2013-11-18
END MARKETING DATE: 0000-00-00


DROSERA ROTUNDIFOLIA HUMAN OTC DRUG Details:

Item DescriptionDROSERA ROTUNDIFOLIA from HOMEOLAB USA INC.
LABELER NAME: HOMEOLAB USA INC.
DEA SCHEDULE:
ACTIVE STRENGTH: 1([hp_X]/1)
START MARKETING DATE: 2013-11-18
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60512-1015_7baaa926-234f-488a-983e-e11c8758d6b8
PRODUCT NDC: 60512-1015
APPLICATION NUMBER:

Other DROSERA ROTUNDIFOLIA Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
HOMEOLAB USA INC.DROSERA ROTUNDIFOLIA
Laboratoires BoironDrosera rotundifolia
Natural Health SupplySpasmodic Cough
Rxhomeo Private Limited d.b.a. Rxhomeo, IncDROSERA ROTUNDIFOLIA
Washington Homeopathic ProductsDrosera rotundifolia